154 related articles for article (PubMed ID: 25232966)
41. Synthesis, NMR conformational analysis and pharmacological evaluation of 7,7a,13,14-tetrahydro-6H-cyclobuta[b]pyrimido[1,2-a:3,4-a']diindole analogues as melatonin receptor ligands.
Attia MI; Güclü D; Hertlein B; Julius J; Witt-Enderby PA; Zlotos DP
Org Biomol Chem; 2007 Jul; 5(13):2129-37. PubMed ID: 17581657
[TBL] [Abstract][Full Text] [Related]
42. Application of the bridgehead fragments for the design of conformationally restricted melatonin analogues.
Zefirova ON; Baranova TY; Ivanova AA; Ivanov AA; Zefirov NS
Bioorg Chem; 2011 Apr; 39(2):67-72. PubMed ID: 21419469
[TBL] [Abstract][Full Text] [Related]
43. MT1-selective melatonin receptor ligands: synthesis, pharmacological evaluation, and molecular dynamics investigation of N-{[(3-O-substituted)anilino]alkyl}amides.
Rivara S; Pala D; Lodola A; Mor M; Lucini V; Dugnani S; Scaglione F; Bedini A; Lucarini S; Tarzia G; Spadoni G
ChemMedChem; 2012 Nov; 7(11):1954-64. PubMed ID: 22927210
[TBL] [Abstract][Full Text] [Related]
44. XFEL structures of the human MT
Johansson LC; Stauch B; McCorvy JD; Han GW; Patel N; Huang XP; Batyuk A; Gati C; Slocum ST; Li C; Grandner JM; Hao S; Olsen RHJ; Tribo AR; Zaare S; Zhu L; Zatsepin NA; Weierstall U; Yous S; Stevens RC; Liu W; Roth BL; Katritch V; Cherezov V
Nature; 2019 May; 569(7755):289-292. PubMed ID: 31019305
[TBL] [Abstract][Full Text] [Related]
45. Quinazoline and phthalazine derivatives as novel melatonin receptor ligands analogues of agomelatine.
Bolteau R; Descamps F; Ettaoussi M; Caignard DH; Delagrange P; Melnyk P; Yous S
Eur J Med Chem; 2020 Mar; 189():112078. PubMed ID: 32004937
[TBL] [Abstract][Full Text] [Related]
46. Mapping the melatonin receptor. 7. Subtype selective ligands based on beta-substituted N-acyl-5-methoxytryptamines and beta-substituted N-acyl-5-methoxy-1-methyltryptamines.
Tsotinis A; Vlachou M; Papahatjis DP; Calogeropoulou T; Nikas SP; Garratt PJ; Piccio V; Vonhoff S; Davidson K; Teh MT; Sugden D
J Med Chem; 2006 Jun; 49(12):3509-19. PubMed ID: 16759094
[TBL] [Abstract][Full Text] [Related]
47. Molecular cloning and pharmacological characterization of rat melatonin MT1 and MT2 receptors.
Audinot V; Bonnaud A; Grandcolas L; Rodriguez M; Nagel N; Galizzi JP; Balik A; Messager S; Hazlerigg DG; Barrett P; Delagrange P; Boutin JA
Biochem Pharmacol; 2008 May; 75(10):2007-19. PubMed ID: 18384758
[TBL] [Abstract][Full Text] [Related]
48. N-(Phenoxyalkyl)amides as MT(1) and MT(2) ligands: antioxidant properties and inhibition of Ca(2+)/CaM-dependent kinase II.
Carocci A; Catalano A; Bruno C; Lovece A; Roselli MG; Cavalluzzi MM; De Santis F; De Palma A; Rusciano MR; Illario M; Franchini C; Lentini G
Bioorg Med Chem; 2013 Feb; 21(4):847-51. PubMed ID: 23332368
[TBL] [Abstract][Full Text] [Related]
49. Preferential formation of MT1/MT2 melatonin receptor heterodimers with distinct ligand interaction properties compared with MT2 homodimers.
Ayoub MA; Levoye A; Delagrange P; Jockers R
Mol Pharmacol; 2004 Aug; 66(2):312-21. PubMed ID: 15266022
[TBL] [Abstract][Full Text] [Related]
50. Recent advances in the development of melatonin MT(1) and MT(2) receptor agonists.
Mor M; Rivara S; Pala D; Bedini A; Spadoni G; Tarzia G
Expert Opin Ther Pat; 2010 Aug; 20(8):1059-77. PubMed ID: 20533893
[TBL] [Abstract][Full Text] [Related]
51. Structural basis of the ligand binding and signaling mechanism of melatonin receptors.
Wang Q; Lu Q; Guo Q; Teng M; Gong Q; Li X; Du Y; Liu Z; Tao Y
Nat Commun; 2022 Jan; 13(1):454. PubMed ID: 35075127
[TBL] [Abstract][Full Text] [Related]
52. Homology models of melatonin receptors: challenges and recent advances.
Pala D; Lodola A; Bedini A; Spadoni G; Rivara S
Int J Mol Sci; 2013 Apr; 14(4):8093-121. PubMed ID: 23584026
[TBL] [Abstract][Full Text] [Related]
53. Characterization of the various functional pathways elicited by synthetic agonists or antagonists at the melatonin MT
Legros C; Dupré C; Brasseur C; Bonnaud A; Bruno O; Valour D; Shabajee P; Giganti A; Nosjean O; Kenakin TP; Boutin JA
Pharmacol Res Perspect; 2020 Feb; 8(1):e00539. PubMed ID: 31893123
[TBL] [Abstract][Full Text] [Related]
54. Melatonin receptors as therapeutic targets in the suprachiasmatic nucleus.
Pévet P
Expert Opin Ther Targets; 2016 Oct; 20(10):1209-18. PubMed ID: 27082492
[TBL] [Abstract][Full Text] [Related]
55. Investigational selective melatoninergic ligands for receptor subtype MT2.
Wan N; Zhang FF; Ju J; Liu DZ; Zhou SY; Zhang BL
Mini Rev Med Chem; 2013 Aug; 13(10):1462-74. PubMed ID: 23815579
[TBL] [Abstract][Full Text] [Related]
56. Synthesis of 3-phenylnaphthalenic derivatives as new selective MT(2) melatoninergic ligands.
Poissonnier-Durieux S; Ettaoussi M; Pérès B; Boutin JA; Audinot V; Bennejean C; Delagrange P; Caignard DH; Renard P; Berthelot P; Lesieur D; Yous S
Bioorg Med Chem; 2008 Sep; 16(18):8339-48. PubMed ID: 18778943
[TBL] [Abstract][Full Text] [Related]
57. N-(Anilinoethyl)amides: design and synthesis of metabolically stable, selective melatonin receptor ligands.
Rivara S; Vacondio F; Fioni A; Silva C; Carmi C; Mor M; Lucini V; Pannacci M; Caronno A; Scaglione F; Gobbi G; Spadoni G; Bedini A; Orlando P; Lucarini S; Tarzia G
ChemMedChem; 2009 Oct; 4(10):1746-55. PubMed ID: 19728346
[TBL] [Abstract][Full Text] [Related]
58. Development of substituted N-[3-(3-methoxylphenyl)propyl] amides as MT(2)-selective melatonin agonists: improving metabolic stability.
Hu Y; Zhu J; Chan KH; Wong YH
Bioorg Med Chem; 2013 Jan; 21(2):547-52. PubMed ID: 23228808
[TBL] [Abstract][Full Text] [Related]
59. Design and synthesis of N-(3,3-diphenylpropenyl)alkanamides as a novel class of high-affinity MT2-selective melatonin receptor ligands.
Bedini A; Spadoni G; Gatti G; Lucarini S; Tarzia G; Rivara S; Lorenzi S; Lodola A; Mor M; Lucini V; Pannacci M; Scaglione F
J Med Chem; 2006 Dec; 49(25):7393-403. PubMed ID: 17149869
[TBL] [Abstract][Full Text] [Related]
60. Alternative Radioligands for Investigating the Molecular Pharmacology of Melatonin Receptors.
Legros C; Brasseur C; Delagrange P; Ducrot P; Nosjean O; Boutin JA
J Pharmacol Exp Ther; 2016 Mar; 356(3):681-92. PubMed ID: 26759496
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]